| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Infectious Diseases (Drs. Husni and Gordon), Pulmonary and Critical Care Medicine (Drs. Goldstein, Arroliga, and Stoller), Infection Control (Ms. Fatica), and Laboratory Medicine (Dr. Hall), Cleveland Clinic Foundation, Cleveland, OH.
Correspondence to: Alejandro C. Arroliga, MD, FCCP, Department of Pulmonary and Critical Care Medicine - G62, Cleveland Clinic Foundation, Cleveland, OH 44195; e-mail: arrolia{at}cesmtp.ccf.org
Introduction: Acinetobacter baumanii is a Gram-negative coccobacillus that is normally a commensal pathogen but can be a nosocomial pathogen. An epidemiologic study was performed to investigate an outbreak of A baumanii that occurred in our medical intensive care unit (MICU) from March to September 1995.
Methods: A case-control study was performed by retrospective chart review, comparing case patients to randomly selected patients who were mechanically ventilated in the MICU for at least 1 week during the outbreak. A case patient was defined as any patient with an Acinetobacter infection in which the epidemic strain was considered to be a pathogen. The epidemic strain was defined by its antibiogram. Case patients and control patients were compared for age, gender, underlying disease, acute physiology and chronic health evaluation III score, length of MICU stay, prior antibiotic use, presence of fever, sepsis, type of pulmonary infiltrate, and outcome. Environmental and hand-washing studies also were performed during the period of the outbreak. Molecular typing was performed on available bloodstream isolates.
Results: There were 15 cases of A baumanii nosocomial pneumonia. Fifty percent were bacteremic; one chart was unavailable for review. Twenty-nine patients were identified as control patients. The mean age for case patients was 50 (range, 21 to 84). The mean duration of time from admission to the ICU to infection was 12.8 days (range, 4 to 40). Sepsis developed in 35% of the case patients. Forty-three percent of the case patients died during their hospitalization, with two of those deaths attributed to Acinetobacter infection. Univariate analysis showed that prior use of ceftazidime was associated with infection with Acinetobacter (11/14 case patients compared to 11/29 control patients; p < 0.01). Pulsed-field gel electrophoresis revealed two strains to be responsible for the outbreak. Hand washing was performed before patient contact by only 10% of health-care workers, and only 32% washed their hands after patient contact.
Conclusion: The use of ceftazidime was associated with an increased risk of nosocomial pneumonia with resistant strains of Acinetobacter. Health-care workers need to improve compliance with hand-washing recommendations.
Key Words: Acinetobacter baumanii • nosocomial infections • pneumonia
This article has been cited by other articles:
|
|
 |
|
  P. Pancholi, M. Healy, T. Bittner, R. Webb, F. Wu, A. Aiello, E. Larson, and P. D. Latta Molecular Characterization of Hand Flora and Environmental Isolates in a Community Setting J. Clin. Microbiol., October 1, 2005; 43(10): 5202 - 5207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nseir, C. Di Pompeo, P. Pronnier, S. Beague, T. Onimus, F. Saulnier, B. Grandbastien, D. Mathieu, M. Delvallez-Roussel, and A. Durocher Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome Eur. Respir. J., December 1, 2002; 20(6): 1483 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. S. Houang, Y. W. Chu, C. M. Leung, K. Y. Chu, J. Berlau, K. C. Ng, and A. F. B. Cheng Epidemiology and Infection Control Implications of Acinetobacter spp. in Hong Kong J. Clin. Microbiol., January 1, 2001; 39(1): 228 - 234. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
